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Abstract 
 
Background: Atherosclerosis in patients with Rheumatoid Arthritis (RA) may be exacerbated by obesity. Aim: To investigate the 
dietary conditions of patients with RA. Methods: This cross-sectional study comprised 105 patients with RA in the department 
of Rheumatology of the University Hospital Centre: “Mother Theresa”, in Tirana, Albania. They were examined for 
demographic, medical activity and dietary conditions. Finally, we assessed the measurement of body mass index (BMI), waist-
hip ratio; triceps skin fold measure (TSF) and its capability bicipital skin fold (BSF) and their sufficiency and arm muscle 
circumference (AMC) and its satisfactoriness. Allied studies of nominal records were done using Fisher and chi-square test. 
Unpaired Student t tests and Mann Whitney were applied for numerical data. The Spearman test was exploited for correlation 
estimates. Results: There were 13/105 men, 92/105 women included in the survey. The mean age was 53.2 ± 10.8 years and 
mean illness extent of 10.4 ± 7.51 years in the whole sample. The mean waist-hip percentage was 0.89 ± 0.08. Along with BMI 
28.6 % had normal weight; 63.8 % an overall weight more than normal. In relation to BSF, 71.6 % were normal and 25.5 % had 
reduction of muscular mass; in proportion to TSF, 79.3% were normal and 15.2% diminished. Alliance of dietary variables with 
sex, rheumatoid factor, age, nodules, and illness activity demonstrated no dissimilarities (p = NS) apart from a lower waist/hip 
proportion in patients with nodules (p = 0.01) and a diffident correlation of TSF with malady length (p = 0.01; R = 0.18; 95% CI 
= 0.01 to 0.30). Conclusion: We discovered a high prevalence of overweight and obesity in patients with RA and a little 
occurrence of muscle diminution. 
 
 
 
1. Introduction 
 
Rheumatoid arthritis (RA) is a persistent, progressive, inflammatory disease distinguished by proportioned, destructive 
polyarthritis and is related to universal symptoms, consisting of tiredness and cachexia. (1̻4). It is the most widespread 
appearance of inflammatory polyarthritis (IP), with a global prevalence in adults of almost 1% (5). RA involves women 
more frequently than men by a fraction of 3: 1. Even though the age of commencement in women is in the sixth decade, it 
can arise at any age. The etiology of rheumatoid arthritis (RA), remains mainly unidentified, even if microbiological, 
immune, genetic, hormonal, and nutritional features have been involved in its pathogenesis (6) 
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RA is one of the more frequent autoimmune syndromes, which exceeds a number of other situations, comprising 
psoriasis, Crohn’s disease, Type I (insulin-dependent) diabetes, lupus, and multiple sclerosis (7,8) 
 
 
 
There is an amplified risk for cardiovascular episodes which is correlated with (9,10) a diminished life expectancy (10) in 
patients with RA. They have a fourfold increased frequency of acute myocardial infarction (11).  
The pathogenesis of accelerated coronary (12)and extra coronary (13) atherosclerosis as an attribute of RA has 
not been evidently described (14) and the pathogenesis has not been evidently described (14). This pathogenesis is 
influenced by the high prevalence of conventional cardiovascular risk factors and the general inflammatory procedure. 
Work absence, premature retirement and financial failures (15,16, 17) are the outcome of combined pain and exhaustion 
connected with the inflammatory progression, malformations that obstruct the presentation of daily activities. Accelerated 
atherosclerosis by the persistent inflammatory course with successive cardiovascular consequences engages an 
outstanding role amid the reasons of enhanced mortality in these patients (18,19, 20). It has been distinguished through 
the previous decade , that RA relates with distorted body composition, differentiated by decreased lean mass and 
frequently maintained or augmented fat mass, linked with preserved or bigger body mass index (BMI) (21), a 
circumstance supposed to speed up morbidity and mortality in RA (22). While adjusting for co morbidity and RA 
harshness, survival benefit detected in obese patients with RA corresponding to individuals with the lowest BMI was lost 
(23). It is pointed out that raised BMI defends the joints by the surveys of the impact of BMI on joint demolition. 
Consequently, patients with early RA and a BMI 27 kg/m2 had a reduced amount of continuous joint obliteration over 2 
years than those with a BMI<27 kg/m2 (24). It is assessed that a RA patient is 1.5 to 2 times more expected to have 
myocardial infarction than the common people. This hazard is analogous to that of a patient with diabetes mellitus type 2 
and can be enhanced by the habitual risk factors like obesity (25). In this perspective, one can conclude that dietary 
factors should be revised and cured in RA, considering the genetic consignment and lifestyle of the population. In the 
current work we investigated the dietary condition of patients with RA in Albanian population. 
 
2. Methods  
 
This is a cross-sectional survey accepted by the Scientific Board of the Faculty of Medicine, Tirana, Albania; where all the 
subjects signed the informal agreement. The participants met no less than four of the categorization principles for a 
diagnosis of RA of the American College of Rheumatology 1987(17) aged among 17 and 78 years old. There were left 
out pregnant women and persons with uninhibited hypothyroidism. 
The staff of the project was trained to carry out the anthropometric measurements like body weight, height, waist 
circumference, hip circumference, arm circumference, biceps and triceps skin folds. The weight and height measurement 
were achieved by applying a digital balance Mars® and a stadiometer Cardiomed® correspondingly. The body mass 
index (BMI) was estimated by splitting weight in kilograms by height in squared meters (26). An inelastic anthropometric 
strip in relation to the Cuppari technique (27) was utilized to measure the circumferences of the hip, arm and waist. Prior 
to standardized procedures illustrated by Cuppari(27) were performed the dimensions of skin fold thickness of biceps and 
triceps with a Cescorf® caliper. The appraisal of skin folds capability was illustrated by Frisancho (28) and affirms that the 
patient is in harsh undernourishment when the sufficiency of arm muscle circumference is below 70%, with restrained 
malnutrition when it is among 70% and 80%, with soft malnutrition when amid 80% to 90% and euthrophic when above 
90%.  
Health evidences of patients were appraised to acquire demographic and medical statistics, illness extent, and 
autoantibody outline such as rheumatoid factor (RF), malady activity (calculated by DAS28 4v) (29, 30). Data were 
gathered on the occurrence and contingency tables. We applied the Fisher and chi-square tests for association studies of 
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nominal data, and Mann Whitney and unpaired Student t tests was performed for numerical data. The Spearman test was 
utilized for correlation estimates. The computations were made using SPSS 20.0 for Windows.  
 
3. Results 
 
There were 13(13.7%) men and 92 (86.2%) women from the total of 105 patients, aged from 23 to 80 years (mean 53.2 ± 
10.8 years). The age at diagnosis was among 20 and 69 years (mean 40.7 ± 11.6 years) and malady extent amid 1 and 
35 years (median 8 years; IQI = 5-13,8). Rheumatoid nodules were noticed in 9.6 % of the participants. Rheumatoid 
factor was affirmative in 64.8%. The DAS28 varied from 0.68 to 7.76 (mean 3.49 ± 1.48) and demonstrated that 15.8 % 
of individuals had elevated activity, 31.4 % had restrained activity, 21.2% had little activity and 27.8% were in RA 
reduction. An investigation of therapies illustrated that 72.9 % were on glucocorticoid (dose: 2.5 mg to 60 
mg/prednisone/day; median 9 mg), 63.7 % applied methotrexate, 43.7 % antimalarial; 28.6 % leflunomide; 14.3 % 
biological therapy (13/105 anti TNF-Į and 1/105 abatacept); 10.3 % sulphasalazine and 2.6% azathioprine. 
The BMI of patients ranged among 16.0 and 45.5 kg/m2 (mean of 27.9 ± 5.7 kg/m2). The BMI allocation in the 
sample could be realized in Fig. 1, which explained that the majority of patients were beyond the acknowledged weight. 
The survey of the connection among waist and hip dimensions confirmed values among 0.75 and 1.14 (mean 0.92 ± 
0.07). In 11/102 (10.7%), the waist hip ratio went beyond 1.0. Concerning arm circumference capability, we examined 
that it varied from 68.6% to 136.2% (mean 99.9 ± 13.7%), and in proportion to this, 74.5% of the individuals were 
eutrophic, 24.5% had soft depletion and 0.98% had harsh muscle reduction. The study of triceps skin fold sufficiency 
demonstrated values amid 24.4% and 336.4% (median 94.4%; IQI = 66.7-112.6). The delivery of findings concerning 
triceps skin fold capability could be seen in Fig. 2, that confirmed half of patients have some grade of exhaustion. The 
examination of arm muscle circumference sufficiency demonstrated values among 76.7% and 142.4% (mean 103.3 ± 
14.2%). Regarding this assessment 83.3% of the population was eutrophic, 12.7% had soft depletion and 4% had 
restrained depletion. 
There wasn’t discovered any relation/correlation between BMI, waist-hip ratio, brachial skin fold adequacy, triceps 
skin fold sufficiency and capability of arm muscle circumference with participants sex, occurrence of rheumatoid factor, 
age, malady activity measured by DAS28 4v and application of glucocorticoids (p = NS). Patients without nodules have 
an elevated significance of waist-hip (p = 0.02) .There was a reserved correlation among triceps skin fold capability and 
disease extent (p = 0.02; R = 0.22; 95% CI 0.01 to 0.40). 
 
 
 
Fig. 1 – Prevalence (in %) of body mass index (BMI) in 105 patients with RA.  
 
 
 
Fig. 2 – Delivery of discoveries of triceps skin fold capability (in %). Analysis of 105 RA patients 
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4. Discussion 
 
The outcomes of this survey has demonstrated that the majority of patients with RA has been beyond normal weight. This 
is an surveillance previously made by other investigators: a multicenter survey confirmed a prevalence of obesity in 18% 
of RA patients (31) An additional survey, performed in England gave a higher prevalence, of 31%(32). In these surveys 
equally over 60% of participants had an upper than preferred weight. Furthermore, we have noticed in the current 
examination that, despite the augmented BMI, nearly all patients had standard or reduced triceps skin fold. Augmented 
BMI has been detected at the expense of adipose tissue before muscle achievement by the present results. There are 
numerous aspects that contribute to an enlarged body fat and a diminished muscle accumulation in a patient with RA. 
Certainly, the inactivity enforced by a hurting and crippling joint illness has to be emphasized (33). First inactivity lessens 
energy spending, afterward it guides to muscle deterioration. Another causal issue is the application of drugs such as 
glucocorticoids that cause bigger appetite and fat increase (34). Enlarged body mass has significant repercussions for 
these patients, despite the etiology. Initially it is the automatic burden forced on the joints, particularly those of the lower 
limbs, which are previously deteriorated by constant inflammation (35) They will undergo structural injure more 
effortlessly guiding to minor osteoarthritis. Even though in RA atherosclerotic malady is mainly secondary to inflammation, 
it also suffers influence of traditional risk factors including obesity(36). The sum of traditional risk factors and inflammation 
will increase the chance of stroke and myocardial infarction. 
According to Kremers et al (37) obesity increases 10-fold the risk of a cardiovascular event in patients with RA. 
The function of adipose tissue on the inflammatory development is a third repercussion. Generally, elevated levels of 
adipokines are the base of the enhancement in the inflammatory procedure in such a way that obesity is presently 
distinguished as a pro inflammatory condition (36). Distorted serum adipokine levels are correlated with rheumatoid 
arthritis (38). Obesity for itself is related with augmented hazard of developing RA (38) regarding several authors. 
Nevertheless data in this last topic are opposing (37,39). It was not noticed association of the application of 
glucocorticoid with dietary condition. It is recognized from literature that this drug is correlated with weight achievement 
and augmented abdominal fat deposition (40). As it is typically done in rheumatoid arthritis, the justification for this result 
is that the majority of our patients were using little doses of this drug. The association with growing glucocorticoid 
revelation could suggest additional information, but regrettably we did not have it. While we used only skin folds as a 
measurement of dietary condition , it can be perceived as a restriction; surveys with DEXA could recommend 
supplementary information. In summary, it can be stated that there is a weight grow in individuals with RA regardless of 
the loss of muscle accumulation, generally at the expense of adipose tissue. Obesity accumulation must be correctly 
thought about so as to best treat patients with this malady. 
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